Variability of 18F-FDG-positive lung lesion volume by thresholding

European Radiology

Volumn 23, Issue 4, 2013, Pages 1131-1137

  Laffon, Eric ^a,b,c   De Clermont, Henri ^b   Marthan, Roger ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

F FDG PET; Lung cancer; Metabolic active volume; Reproducibility; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG VOLUME; MALE; MEASUREMENT ERROR; PRIORITY JOURNAL; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TUMOR VOLUME;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 84878617989     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2672-2     Document Type: Article

References (21)

1. Zasadny KR, Kison PV, Francis IR, Wahl RL (1998) FDG-PET determination of metabolically active tumor volume and comparison with CT. Clin Positron Imaging 1:123-129
2. Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, Humm JL (1997) Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80:2505-2509
3. Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A (2007) Segmentation of PET volumes by iterative image thresholding. J Nucl Med 48:108-114
4. Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Grégoire V (2003) Tridimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of the reconstruction algorithms. Radiother Oncol 69:247-250
5. Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D (2004) Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 690:1272-1282
6. 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:453-462
7. Visser EP, Boerman OC, Oyen WJG (2010) SUV: from silly useless value to smart uptake value. J Nucl Med 51:173-175
8. Bland JM, Altman DG (1996) Statistics notes: Measurement error. BMJ 313:744-746
9. Bland JM, Altman DG (1996) Statistics notes: Measurement error proportional to the mean. BMJ 313:106-108
10. De Ruysscher D, Nestle U, Jeraj R, MacManus M (2012) PET scans in radiotherapy planning of lung cancer. Lung Cancer 75:141-145
11. Feng M, Kong F-M, Gross M, Fernando S, Hayman JA, Ten Haken RK (2009) Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 73:1228-1234
12. Edet-Sanson A, Dubray B, Doyeux K, Back A, Hapdey S, Modzelewski R, Bohn P, Gardin I, Vera P (2011) Serial assessment of FDG-PET uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC). Radiother Oncol 102:251-257
13. 18F-FDG PET. J Nucl Med 51:268-276
14. Frings V, de Langen AJ, Smit EF, van Helden FH, Hoekstra OS, van Tinteren H, Boellaard (2010) Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer. J Nucl Med 51:1870-1877
15. Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932-945
16. 18F-FDG uptake measurements in tumours: a meta-analysis. J Nucl Med 53:701-708
17. Boellaard R (2011) Need for standardization of 18F-FDG PET/CT for treatment response assessments. J Nucl Med 52:93S-100S
18. 18F-FDG PET imaging. Eur Radiol 21:2417-2424
19. Nakamoto Y, Zadsadny KR, Minn H, Wahl R (2002) Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-Deoxy-2-[18F]Fluoro-D-Glucose. Molecular Imaging and Biology 4:171-178
20. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thor Oncol 2:706-714
21. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC, Cosset JM, Housset M, Touboul E (2000) Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48:1015-1024